ARHGAP19 Antikörper (Middle Region)
-
- Target Alle ARHGAP19 Antikörper anzeigen
- ARHGAP19 (rho GTPase Activating Protein 19 (ARHGAP19))
-
Bindungsspezifität
- AA 202-232, Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ARHGAP19 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human RHG19 (Center).
- Aufreinigung
- Affinity Chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 202~232 amino acids from the Central region of Human RHG19 Genename: ARHGAP19
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ARHGAP19 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- ARHGAP19 (rho GTPase Activating Protein 19 (ARHGAP19))
- Andere Bezeichnung
- ARHGAP19 (ARHGAP19 Produkte)
- Hintergrund
- Members of the ARHGAP family, such as ARHGAP19, encode negative regulators of Rho GTPases (see RHOA, MIM 165390), which are involved in cell migration, proliferation, and differentiation, actin remodeling, and G1 cell cycle progression.Synonyms: Rho GTPase-activating protein 19, Rho-type GTPase-activating protein 19
- Molekulargewicht
- 55756 Da
- Gen-ID
- 84986
- NCBI Accession
- NP_001191229
-